New England Capital Financial Advisors LLC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1964652
MERIDEN, CT
Position in TMO
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$5,514
+$108 QoQ
Shares Held
11
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2,564
of 2,606 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026New England Capital Financial Advisors LLC holds $91,121 across 6 Diagnostics & Research names. TMO ranks #3 (6.1% of the industry book) .
All Filings in TMO
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,514 | 11 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $5,406 | 11 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $6,373 | 11 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $5,335 | 11 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $4,460 | 11 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $5,473 | 11 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $5,722 | 11 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $6,804 | 11 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $6,083 | 11 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $6,393 | 11 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $5,838 | 11 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $5,567 | 11 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $5,739 | 11 | Shares | Sole | 2023-08-02 | |
| No filing history on record for this holder in this stock. | ||||||